skip to main content
Southern Health NHS Foundation Trust

Current Studies

PLEASE NOTE THAT MANY OF OUR STUDIES HAVE BEEN PAUSED DUE TO COVID-19. PLEASE CONTACT US ON 07920806858 IF YOU HAVE ANY QUERIES ABOUT SPECIFIC STUDIES FIND STUDIES THAT ARE RUNNING BELOW.

We support research for a wide range of services, across mental health, memory disorders (MARC),  learning disabilities and community based care. Please click on the below categories to see relevant current studies. 

Studies currently recruiting  
  • Psychological impact of the Coronavirus (COVID-19) pandemic and experience: An international surveyA 15 minute questionnaire to assess the impact of COVID-19 (Coronavirus) on behaviours and mental wellbeing across a global population
  • Hearing Nasty VoicesA questionnaire study for those who experience derogatory or threatening voices.
  • CLIMBA study to establish the opinions of the public with regards to sharing identified NHS data for clinical purposes and de-identified data for research purposes.
  • A Survey of Preferences for the Arts TherapiesA short survey to gain people's opinions about the use of the different genres of Arts Therapies.
  • FEATSOCsThis study aims to see if Transcranial direct current stimulation (tDCS) can be used to help treat people with obsessive compulsive disorder.
  • CaFI StudyThis study aims to test the effectiveness of a more Culturally-adapted Family Intervention (CaFI) for Sub Saharan African and Caribbean people with schizophrenia and psychosis in the UK and their families.
  • GLADThis is an opportunity for anyone who has or is suffering with anxiety or depression to take part in the biggest study of it's kind, looking at the factors behind anxiety and depression.
  • PPiP2This study aims to estimate the prevalence of antibodies against neuronal cell surface targets in patients with psychotic symptoms.

Studies currently recruiting     

  • SELECTThe SELECT study is being done to see if semaglutide can reduce the risk of cardiovascular events such as heart attack or stroke.
  • BI 456906, sponsored by Boehringer Ingelheim Ltd.A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetes.
  • Screening of Target Genes (Asthma)Screening of target genes for polymorphic variation which may alter treatment response for airway treatment targets.
  • Quality of Life InjectableAn observational study looking at the effect of injectable therapies on health status, quality of life and treatment satisfaction in patients with type 2 diabetes.
Studies currently recruiting 
Page Comments